Oruka Therapeutics, Inc. (ORKA) Earnings
|
Expand Research on ORKA
| Next EPS Date | 11/18/26 | EPS Growth Rate | -5.5% |
|---|---|---|---|
| Average EPS % Beat Rate | -2.0% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +5.1% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/18/26  |
Q326 | N/A | -$0.58 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/10/26 |
Q226 | -$0.55 | -$0.51 | -$0.04 | N/A | N/A | N/A |  | | Details | |
| 5/13/26 | Q126 | -$0.48 | $0.00 | -$0.48 | N/A | N/A | N/A | | | Details | |
| 3/12/26 | Q425 | -$0.45 | $0.00 | -$0.45 | N/A | N/A | N/A | | | Details | |
| 11/13/25 | Q325 | -$0.55 | $0.00 | -$0.55 | N/A | N/A | N/A | | | Details | |
| 8/11/25 |
Q225 | N/A | -$0.66 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/25 |
Q225 | N/A | -$0.66 | N/A | N/A | N/A | N/A | N/A | N/A | ||
| 8/11/25 |
Q225 | N/A | -$0.66 | N/A | N/A | N/A | N/A | N/A | N/A |
